Подписаться
Michael J. Mina, MD, PhD
Michael J. Mina, MD, PhD
Harvard School of Public Health, Harvard Medical School
Подтвержден адрес электронной почты в домене hsph.harvard.edu
Название
Процитировано
Процитировано
Год
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
K Bjornevik, M Cortese, BC Healy, J Kuhle, MJ Mina, Y Leng, SJ Elledge, ...
Science 375 (6578), 296-301, 2022
12612022
Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening
DB Larremore, B Wilder, E Lester, S Shehata, JM Burke, JA Hay, ...
Science advances 7 (1), eabd5393, 2021
1022*2021
Rethinking Covid-19 test sensitivity—a strategy for containment
MJ Mina, R Parker, DB Larremore
New England Journal of Medicine 383 (22), e120, 2020
8062020
Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality
MJ Mina, CJE Metcalf, RL De Swart, A Osterhaus, BT Grenfell
Science 348 (6235), 694-699, 2015
4482015
To interpret the SARS-CoV-2 test, consider the cycle threshold value
MR Tom, MJ Mina
Clinical Infectious Diseases 71 (16), 2252-2254, 2020
4292020
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens
MJ Mina, T Kula, Y Leng, M Li, RD De Vries, M Knip, H Siljander, ...
Science 366 (6465), 599-606, 2019
3842019
Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years
CM Saad-Roy, CE Wagner, RE Baker, SE Morris, J Farrar, AL Graham, ...
Science 370 (6518), 811-818, 2020
2492020
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes
CM Saad-Roy, SE Morris, CJE Metcalf, MJ Mina, RE Baker, J Farrar, ...
Science 372 (6540), 363-370, 2021
2122021
COVID-19 testing: One size does not fit all
MJ Mina, KG Andersen
Science 371 (6525), 126-127, 2021
2122021
Estimating epidemiologic dynamics from cross-sectional viral load distributions
JA Hay, L Kennedy-Shaffer, S Kanjilal, NJ Lennon, SB Gabriel, M Lipsitch, ...
Science 373 (6552), eabh0635, 2021
1712021
Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward
JE Bryant, AS Azman, MJ Ferrari, BF Arnold, MF Boni, Y Boum, K Hayford, ...
Science immunology 5 (47), eabc6347, 2020
1662020
Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19
MJ Mina, TE Peto, M García-Fiñana, MG Semple, IE Buchan
The Lancet 397 (10283), 1425-1427, 2021
1642021
JAM-A associates with ZO-2, afadin, and PDZ-GEF1 to activate Rap2c and regulate epithelial barrier function
AC Monteiro, R Sumagin, CR Rankin, G Leoni, MJ Mina, DM Reiter, ...
Molecular biology of the cell 24 (18), 2849-2860, 2013
1252013
Drivers of airborne human-to-human pathogen transmission
S Herfst, M Böhringer, B Karo, P Lawrence, NS Lewis, MJ Mina, ...
Current opinion in virology 22, 22-29, 2017
1202017
Vaccine nationalism and the dynamics and control of SARS-CoV-2
CE Wagner, CM Saad-Roy, SE Morris, RE Baker, MJ Mina, J Farrar, ...
Science 373 (6562), eabj7364, 2021
1032021
Reopening scenarios
D Baqaee, E Farhi, MJ Mina, JH Stock
National Bureau of Economic Research, 2020
932020
Live Attenuated Influenza Vaccine Enhances Colonization of Streptococcus pneumoniae and Staphylococcus aureus in Mice
MJ Mina, JA McCullers, K Keith P
mBio 5 (1), e01040-13, 2014
912014
The role of influenza in the severity and transmission of respiratory bacterial disease
MJ Mina, KP Klugman
The Lancet Respiratory Medicine 2 (9), 750-763, 2014
882014
Seroepidemiologic study designs for determining SARS-COV-2 transmission and immunity
H Clapham, J Hay, I Routledge, S Takahashi, M Choisy, D Cummings, ...
Emerging infectious diseases 26 (9), 1978, 2020
842020
Structural basis for antibody inhibition of flavivirus NS1–triggered endothelial dysfunction
SB Biering, DL Akey, MP Wong, WC Brown, NTN Lo, H Puerta-Guardo, ...
Science 371 (6525), 194-200, 2021
822021
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20